Jafza’s healthcare companies spur seven-fold growth in trade value in 4 years

The UAE’s healthcare sector has expanded significantly over the last decade, with more opportunities and growth on the cards as the nation contributed 54 per cent of the overall healthcare trade in the GCC in 2021. To cater to this growth, where timelines and appropriate handling of products are vital, efficient supply chain solutions play a crucial role in success. From manufacturing and storage to distribution, transportation, and quality assurance, the goal is to ensure safety and reliability without compromise.

Jebel Ali Free Zone (Jafza) plays an important role for the UAE and the wider Mena region, with access to a polyfunctional seaport, specialised logistics facilities and a proven track record of handling sensitive materials under the strictest safety guidelines. For instance, in 2021, DP World partnered with UNICEF to accelerate the distribution of vaccines using Jafza’s facilities to optimise critical supply access for countries most under pressure from the pandemic.

Jafza’s progressive healthcare cluster

Improving the sector’s competitiveness and attractiveness and promoting international best practices in the industry are key to Jafza’s sustainable and innovative healthcare cluster. As a one-stop-destination for all the needs of the healthcare sector, Jafza currently hosts 412 leading healthcare and pharmaceutical companies from 60 countries.

The free zone offers a range of services to healthcare manufacturers, from customised, purpose-built facilities to bio-hazard waste management. Furthermore, with the help of healthcare-focused logistics providers located in the free zone, Jafza offers multimodal transportation services by sea, air and land. This is alongside a customs-bonded corridor, and end-to-end logistics and storage solutions.

Over the last four years, the free zone’s healthcare sector has witnessed a seven-fold increase in trade value in terms of export. In 2021, Jafza’s healthcare companies accounted for nearly half of Dubai’s total trade volume for pharmaceutical and healthcare products.

During the same year, pharmaceutical products and healthcare instruments and appliances worth Dh3.8 billion were imported, up 15 per cent from 2020. The top 10 import markets were France, Germany, USA, Switzerland, Italy, UK, Spain, India, China, and Japan. These countries contributed to 78 per cent of the overall imports of Jafza-based companies.

End-to-end offerings

Jafza also provides an ecosystem that promotes easy business set-up. One of the major advantages for local and global healthcare companies is the ability to carry out a variety of activities, from production to packaging within the free zone.

— muzaffarrizvi@khaleejtimes.com